Sosei has acquired development and commercialization rights to Loramyc in Japan from BioAlliance Pharma. Loramyc is an antifungal agent administered as a mucoadhesive buccal tablet
DentalEZ Group officially launched Identafi, an oral cancer screening device used to detect oral mucosal abnormalities, at the California Dental Association (CDA) 2011 spring meeting
Contrary to previous research, postmenopausal women are not more vulnerable than men to alcohol-induced carcinogenesis in the oral cavity, according to a new study in
For patients suffering from oral and oropharyngeal cancer, a study published March 17 in Head & Neck shows that a treatment called submandibular gland transfer
Chicago White Sox pitcher John Danks is once again partnering with Oral Health America and Little League baseball to promote the message that “smokeless does
Stress and depression are associated with tumor growth in head and neck cancer patients, and they can shorten the time that such patients are able
Though there have been significant improvements in the treatment of head and neck cancer, there is still a lack of data on the experience of
Q: What’s your view of oral cancer screening products? HiRes Rydon loupes by Orascoptic. HiRes Rydon loupes by Orascoptic. A: I am a fan of
The Hulston Cancer Center in Springfield, MO, has a unique program that provides free dental care for cancer patients who need x-rays or extractions before
New research published in the American Journal of Health Promotion shows that population-based approaches to smoking cessation — including mass media campaigns and smoking quit
A team of head and neck surgeons from Mayo Clinic has found that robotic surgery can treat cancer of the larynx, according to research presented
Combining CT with fluorodeoxyglucose positron emission tomography (FDG-PET) imaging results in significantly more defined tumor outlines and potentially different treatment options in head and neck
